# Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/empagliflozin-improves-liver-steatosis-and-fibrosis-in-patients-with-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Haleh Chehrehgosha,Masoudreza Sohrabi,Faramarz Ismail‐Beigi,Mojtaba Malek,Mohammad Reza Babaei,Farhad Zamani,Hossein Ajdarkosh,Mahmoodreza Khoonsari,Afshin Eshghi Fallah,Mohammad E. Khamseh |
| Citations | 175 |
| DOI | 10.1007/s13300-021-01011-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1007/s13300-021-01011-3.pdf |
| OpenAlex ID | https://openalex.org/W3130225195 |
| PMID | 33586120 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Mahmoodreza Khoonsari](https://scholariq.org/researchers/mahmoodreza-khoonsari/)
- [Hossein Ajdarkosh](https://scholariq.org/researchers/hossein-ajdarkosh/)

## Paper journal

- [Diabetes Therapy](https://scholariq.org/journals/diabetes-therapy/)

## Paper primary topic

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Paper topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.